Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Right now, it typically takes six years after an HIV drug approval to obtain data for pregnant people.
Pioneering HIV doctor Paul Volberding and veteran activist Gregg Gonsalves reflect on the legacy of AIDS and its implications for COVID-19.
The new numbers are encouraging but Black and Latino people continue to be disproportionately affected by HIV.
A survey of Black women with HIV found that national policy and cultural beliefs contributed to whether they reported breastfeeding.
Vivent will create an HIV Medical Home in Kansas City, Missouri, where Latinos and Black Americans see higher HIV rates.
HIV treatment usually requires daily pills, but longer-acting regimens are gaining ground.
A study of Black and Latino people living with HIV found high rates of resilience and challenges.
However, it’s still unclear whether Undetectable = Untransmittable extends to breastmilk.
An ongoing randomized controlled trial will provide more definitive results in the future.
Compared with efavirenz-based regimens, dolutegravir-containing ones resulted in fewer switches and better viral control.
The woman has had an undetectable viral load and a normal CD4 count for more than 12 years after stopping antiretroviral therapy.
Middle-aged Black adults living with HIV reported substantial economic impact of COVID-19 and high medical mistrust.
A new CDC model shows the potential power of Undetectable = Untransmittable to curb HIV rates by 2027.
Injectable cabotegravir and rilpivirine are approved for people with viral suppression who would prefer monthly injections to daily pills.
The 1917 Clinic has offered HIV services in Birmingham, Alabama, since 1988.
HIVMA updated its 2013 guidance on providing evidence-based primary care to people with HIV.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.